Sunesis Pharmaceuticals

Region Nordamerika
ISIN US8673288747
Sektor Biotechnologie

Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.

Artikel über Sunesis Pharmaceuticals

Titel Autor Datum
Risikoarmes "Peak Play" mit Multibagger-Potenzial
sharedeals translation missing: de.datetime.time_ago_in_words.almost_x_years